J. Goldman & Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$498K Sell
15,294
-18,364
-55% -$590K 0.02% 505
2025
Q4
$1.18M Buy
+33,658
New +$1.19M 0.05% 365
2025
Q3
Hold
0
700
2025
Q2
Hold
0
716
2025
Q1
Sell
-14,456
Closed -$457K 725
2024
Q4
$582K Buy
+14,456
New +$824K 0.02% 358
2024
Q3
Hold
0
692
2024
Q2
Hold
0
666
2023
Q4
Sell
-92,219
Closed -$1.02M 548
2023
Q3
$1.02M Buy
+92,219
New +$1.32M 0.05% 237
2023
Q1
Hold
0
542
2022
Q4
Sell
-135,000
Closed -$603K 544
2022
Q3
$367K Buy
+135,000
New +$442K 0.03% 311
2019
Q4
Sell
-12,857
Closed -$88K 404
2019
Q3
$88K Buy
+12,857
New +$95.5K 0.01% 266
2018
Q3
Sell
-82,698
Closed -$785K 428
2018
Q2
$785K Buy
+82,698
New +$550K 0.07% 268

Other funds holding VKTX